Innovating Works

BioVersys SAS

Desconocido
TRIC-TB: Boosting Ethionamide efficacy and lowering the dose with a small molecule transcriptional modulators... BioVersys SAS participó en un H2020: H2020-JTI-IMI2-2018-16-single-stage Tuberculosis (TB) is the world’s leading infectious disease. It killed 1.7 million people in 2016 and 10.4 million people developed active T...
2019-05-28 - 2024-02-29 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.